148 related articles for article (PubMed ID: 2500849)
1. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
Perri RT; Kay NE
Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
[TBL] [Abstract][Full Text] [Related]
2. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
3. Differential response of malignant human B-cells to anti-IgM immunoglobulin (anti-mu) and B-cell growth factor: unique direct cytotoxicity of anti-mu on prolymphocytic leukemia cells.
Chan CS; Soehnlen F; Schechter GP
Blood; 1990 Oct; 76(8):1601-6. PubMed ID: 2119832
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
Perri RT; Wilson BS; Kay NE
Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
[TBL] [Abstract][Full Text] [Related]
7. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
Procopio AD; Allavena P; Ortaldo JR
J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
[TBL] [Abstract][Full Text] [Related]
8. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
9. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal.
Karray S; Merle-Béral H; Vazquez A; Gerard JP; Debre P; Galanaud P
Blood; 1987 Oct; 70(4):1105-10. PubMed ID: 3115334
[TBL] [Abstract][Full Text] [Related]
11. Natural killer function in B-chronic lymphocytic leukemia.
Kay NE; Perri RT
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):343-5. PubMed ID: 3065733
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
13. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
Benjamin D; Bazar LS; Wallace B; Jacobson RJ
Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
[TBL] [Abstract][Full Text] [Related]
15. B8.7 antigen expression on B-CLL cells and its relationship to the LMW-BCGF responsiveness.
Karray S; Leprince C; Merle-Beral H; Debre P; Richard Y; Galanaud P
Leuk Res; 1990; 14(9):809-14. PubMed ID: 2232853
[TBL] [Abstract][Full Text] [Related]
16. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
17. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes.
Caligaris-Cappio F; Schena M; Bergui L; Tesio L; Riva M; Rege-Cambrin G; Funaro A; Malavasi F
Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
